News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
NEW ENTERPRISE ASSOCIATES 13 LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/24/2023 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 33.5% stake in Minerva Surgical, Inc. |
| 11/04/2022 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for PhaseBio Pharmaceuticals, Inc. |
| 04/06/2020 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Ra Pharmaceuticals, Inc. |
| 01/14/2020 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 6.4% stake in Dermira, Inc. |
| 10/17/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 13% stake in Ra Pharmaceuticals, Inc. |
| 07/08/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for Epizyme, Inc. |
| 01/30/2019 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP has filed a Schedule 13D for TESARO, Inc. |
| 12/06/2018 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 19% stake in TESARO, Inc. |
| 03/09/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/27/2018 |
SC 13D/A
| NEW ENTERPRISE ASSOCIATES 13 LP reports a 17.7% stake in Ra Pharmaceuticals, Inc. |
| 09/28/2016 |
SC 13D/A
| Roka BioScience, Inc. reports a 37.9% stake in Roka Bioscience, Inc. |
| 03/28/2016 |
SC 13D/A
| TESARO, Inc. reports a 25.6% stake in TESARO, Inc. |
|
|